News

  • 02/14/2014

    IPO: Patrick Alexandre, chief executive of Crossject

    Crossject designed a needle-free injection system, Zeneo, based on high pressure techniques.

    Read more
  • 02/07/2014

    Crossject : Soft flotation

    Crossject, the creator of the needle-free injection device Zeneo is going public with 3 generic molecules. Valuation appears attractive with, moreover, a vast deployment potential.

    Read more

Events

  • 04/16/2014

    Crossject will be present at BIO San Diego 2014

    Meet us in San Diego, June 23th to 26th, during the 2014 BIO international convention. Contact Tim Muller :  t.muller@crossject.com  / Mobile +33 (0)645523540 / skype id: timotheemuller

    Read more
  • 04/16/2014

    Crossject will be present at CPhI 2014

    CPhl, the international pharmaceutical networking event will take place in Paris from october 9 -11 2014.
    To meet us, please contact Tim Muller :  t.muller@crossject.com  / Mobile +33 (0)645523540 / +33(0)602510791 / skype id: timotheemuller

    Read more

video

Discover our needle-free self injectable solution

The desire for safer and more user-friendly injection device to prevent needle-stick injuries...

more videos